Fluconazole-induced acute generalized exanthematous pustulosis

Am J Emerg Med. 2021 Jan:39:254.e5-254.e7. doi: 10.1016/j.ajem.2020.06.061. Epub 2020 Jun 28.

Abstract

Acute generalized exanthematous pustulosis (AGEP) is a rare severe cutaneous adverse reaction usually caused by drugs. The annual incidence is one to five cases per million. It is characterized by an acute febrile episode, accompanied by numerous small primarily non-follicular, sterile pustules arising within large areas of edematous erythema. There have been several case reports to date of AGEP following exposure to antifungals. Terbinafine is most commonly implicated in AGEP. We report a case of 7-year-old boy who developed AGEP shortly after commencing oral fluconazole for Tinea capitis. To our knowledge, this is the fourth reported case of AGEP due to fluconazole.

Keywords: Acute generalized exanthematous pustulosis; Fluconazole.

Publication types

  • Case Reports

MeSH terms

  • Acute Generalized Exanthematous Pustulosis / diagnosis*
  • Acute Generalized Exanthematous Pustulosis / etiology*
  • Antifungal Agents / adverse effects*
  • Child
  • Fluconazole / adverse effects*
  • Humans
  • Male

Substances

  • Antifungal Agents
  • Fluconazole